How color cosmetics merge form with function
UC expert featured in Cosmetics & Toiletries article
The University of Cincinnati's Kelly Dobos was a featured expert in a Cosmetics & Toiletries article explaining trends and innovations in color cosmetics.
Dobos, a cosmetic chemist and adjunct instructor in UC's Cosmetic Science Program in the James L. Winkle College of Pharmacy, said color cosmetics have undergone significant changes to meet consumer demands over the past few years.
"Brands are creating very innovative hybrid products," she said. "Many foundation products today now incorporate skin care benefits, but there’s a lot of room for innovation in eye and lip categories.
"Biotech continues to revolutionize the way cosmetic ingredients can be produced," Dobos continued. "Color additives for cosmetics are regulated in every region around the world and those regulations can vary considerably; and a big challenge for beauty has been finding a globally acceptable true red pigment that can be used in the eye area."
Read the Cosmetics & Toiletries article.
Featured photo at top of cosmetics products. Photo/Shamblen Studios/Unsplash.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.